Shenzhen Kangtai Biological Products Co., Ltd. Stock: price and insider trades · China
康泰生物
No insider purchase over the last 90 days. The latest, by 陶瑾, was filed 31 Jan 2023.
Shenzhen Kangtai Biological Products Co., Ltd.: what insiders have been doing
Every trade that managers of Shenzhen Kangtai Biological Products Co., Ltd. disclose to SSE / SZSE (CSRC) is tracked on this page. The company sits in the Health Care sector and is based in Guangzhou, People's Republic of China. It was founded in 1992. Shenzhen Kangtai Biological Products Co., Ltd. has had no insider filing for more than a year; the last one goes back to 31 January 2023.
Our records for Shenzhen Kangtai Biological Products Co., Ltd. go back to 2021, with 3 purchases and 1 sale on the open market in total.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and Vetoquinol SA. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Since the insiders bought
- -43.5%Entry CN¥37.28 · Close at T+365 CN¥21.08
- -43.5%Entry CN¥37.28 · Close at T+365 CN¥21.08
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 31,300 shares68.4% of flowA股XSHESZSE:173000006248721060Canonical exit: 1 May 2023 (T+90)
- 84,300 shares100.0% of flowA股XSHESZSE:173000006248721100Canonical exit: 1 May 2023 (T+90)
- 14,500 shares31.6% of flowA股XSHESZSE:173000006217927420Canonical exit: 18 Apr 2023 (T+90)
- 130,400 shares100.0% of flowA股XSHESZSE:173000004436311700
4 of 4 declarations
About Shenzhen Kangtai Biological Products Co., Ltd.
康泰生物 is a company in the health and pharmaceutical sector, listed on the XSHE market. It focuses on the development and production of biological and pharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
